RT @JNeurooncol: #OnlineFirst: New Study in the JNO identifies a novel ‘radiomic' signature that may predict 1p/19q co-deletion status in p…
RT @JNeurooncol: #OnlineFirst: New Study in the JNO identifies a novel ‘radiomic' signature that may predict 1p/19q co-deletion status in p…
RT @JNeurooncol: #OnlineFirst: New Study in the JNO identifies a novel ‘radiomic' signature that may predict 1p/19q co-deletion status in p…
RT @JNeurooncol: #OnlineFirst: New Study in the JNO identifies a novel ‘radiomic' signature that may predict 1p/19q co-deletion status in p…
RT @JNeurooncol: #OnlineFirst: New Study in the JNO identifies a novel ‘radiomic' signature that may predict 1p/19q co-deletion status in p…
#OnlineFirst: New Study in the JNO identifies a novel ‘radiomic' signature that may predict 1p/19q co-deletion status in patients with low grade gliomas https://t.co/y9jbyV6DcK https://t.co/WVgLpht8Xe
RT @SprakerMDPhD: One of the better recent studies using radiomics. Clinically useful endpoint, large sample, and inclusion of clinical cov…
One of the better recent studies using radiomics. Clinically useful endpoint, large sample, and inclusion of clinical covariates. Worth a read for sure! https://t.co/KLHbiSBRhn
#newupdatesneuroonc #braintumours #neuroonc Non-invasive genotype prediction of chromosome 1p/19q co-deletion by development and validation of an MRI-based radiomics signature in lower-grade gliomas - https://t.co/Ov9caXItkU